Pre-existing diseases and use of loop diuretics may explain increased mortality in secondary hyperparathyroidism.
Rejnmark
Lars
L
Vestergaard
Peter
P
Mosekilde
Leif
L
D015331:Cohort Studies; D015897:Comorbidity; D006331:Heart Diseases / Q000097:blood / Q000188:drug therapy; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality*; D015201:Meta-Analysis as Topic; D010281:Parathyroid Hormone / Q000097:blood; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014807:Vitamin D / Q000097:blood; D014808:Vitamin D Deficiency / Q000097:blood / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality
D010281:Parathyroid Hormone; D049994:Sodium Potassium Chloride Symporter Inhibitors; D014807:Vitamin D